Aqueous extract of Boerhaavia diffusa root ameliorates ethylene glycol-induced hyperoxaluric oxidative stress and renal injury in rat kidney

Pharmaceutical Biology

Volumn 49, Issue 12, 2011, Pages 1224-1233

  Pareta, Surendra K ^a   Patra, Kartik C ^a   Mazumder, Papiya M ^b   Sasmal, Dinakar ^b  

^a GURU GHASIDAS UNIVERSITY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Antioxidant; Calcium oxalate; Lipid peroxidation; Urolithiasis

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ASCORBIC ACID; BOERHAAVIA DIFFUSA EXTRACT; CATALASE; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITROGEN; OXALIC ACID; PHENOL DERIVATIVE; SCAVENGER; SUPEROXIDE DISMUTASE; UREA; WHEWELLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPEROXALURIA; KIDNEY INJURY; MALE; NEPHROLITHIASIS; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PLANT ROOT; RAT; RENAL PROTECTION; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CATALASE; CHROMATOGRAPHY, THIN LAYER; ETHYLENE GLYCOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYPEROXALURIA; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; NYCTAGINACEAE; OXALIC ACID; OXIDATIVE STRESS; PICRATES; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; WATER;

ANIMALIA; BOERHAVIA DIFFUSA; NYCTAGINACEAE; RATTUS;

EID: 81155125763     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.581671     Document Type: Article

References (54)

1. Antus B, Exton MS, Rosivall L. (2001). Angiotensin II: A regulator of infammation during renal disease? Int J Immunopathol Pharmacol, 14, 25-30.
2. Atmani F, Sadki C, Aziz M, Mimouni M, Hacht B. (2009). Cynodon dactylon extract as a preventive and curative agent in experimentally induced nephrolithiasis. Urol Res, 37, 75-82.
3. Atmani F, Slimani Y, Mimouni M, Hacht B. (2003). Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int, 92, 137-140.
4. Awasthi LP, Verma HN. (2006). Boerhaavia difusa-A wild herb with potent biological and antimicrobial properties. Asian Agri-History, 10, 55-68.
5. Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ. (2007). Te role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series, 5, 26-136.
6. Bashir S, Gilani AH. (2009). Antiurolithic efect of Bergenia ligulata rhizome: An explanation of the underlying mechanisms. J Ethnopharmacol, 122, 106-116.
7. Bijarnia RK, Kaur T, Aggarwal K, Singla SK, Tandon C. (2008). Modulatory efects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney. Food Chem Toxicol, 46, 2274-2278.
8. Budinin R, Tonelli D, Girotti. (1980). Analysis of total phenols using the Prussian blue method. J Agric Food Chem, 28, 1236-1238.
9. Cao ZG, Liu JH, Radman AM, Wu JZ, Ying CP, Zhou SW. (2003). An experimental study of efect of diferent extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats. Zhongguo Zhong Yao Za Zhi, 28, 1072-1075.
10. Chance B, Maehly C. (1955). Assay of catalase and peroxidase. Methods Enzymol, 11, 764-775.
11. Chauhan CK, Joshi MJ, Vaidya ADB. (2009). Growth inhibition of struvite crystals in the presence of herbal extract Boerhaavia difusa Linn. Am J Infect Dis, 5, 177-186.
12. Chopra RN, Ghosh S, Dey P, Ghosh BN. (1923). Pharmacology and therapeutics of Boerhaavia difusa (Punarnava). Ind Med Gaz, 68, 203-208.
13. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. (1968). Screening of Indian plants for biological activity: I. Indian J Exp Biol, 6, 232-247.
14. Dringen R, Hamprecht B. (1996). Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem, 67, 1375-1382.
15. El-Demerdash FM, Yousef MI, Radwan FM. (2009). Ameliorating efect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in diferent rat organs. Food Chem Toxicol, 47, 249-254.
16. Esterbauer H, Cheeseman KH. (1990). Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Meth Enzymol, 186, 407-421.
17. Ferreres F, Sousa C, Justin M, Valentão P, Andrade PB, Llorach R, Rodrigues A, Seabra RM, Leitão A. (2005). Characterisation of the phenolic profle of Boerhaavia difusa L. by HPLC-PAD-MS/MS as a tool for quality control. Phytochem Anal, 16, 451-458.
18. Gaitonde BB, Kulharni HJ, Nabar SD, Joglekar SN. (1974). Diuretic activity of Punarnava (Boerhavia difusa). Bull Hafkine Inst, 2, 24.
19. Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases. Te frst enzymatic step in mercapturic acid formation. J Biol Chem, 249, 7130-7139.
20. Hackett RL, Shevock PN, Khan SR. (1995). Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals. Scanning Microsc, 9, 587-596.
21. Hansen K, Nyman U, Smitt UW, Adsersen A, Gudiksen L, Rajasekharan S, Pushpangadan P. (1995). In vitro screening of traditional medicines for anti-hypertensive efect based on inhibition of the angiotensin converting enzyme (ACE). J Ethnopharmacol, 48, 43-51.
22. Huang HS, Ma MC, Chen CF, Chen J. (2003). Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology, 62, 1123-1128.
23. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. (2005). Examination of the anti-oxidative efect in renal tubular cells and apoptosis by oxidative stress. Urol Res, 33, 261-266.
24. Jonassen JA, Kohjimoto Y, Scheid CR, Schmidt M. (2005). Oxalate toxicity in renal cells. Urol Res, 33, 329-339.
25. Karadi RV, Gadge NB, Alagawadi KR, Savadi R V. (2006). Efect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol, 105, 306-311.
26. Kasana MS, Chauhan N, Prachi. (2009). Plants of Muzafarnagar district used in treatment of urinary tract and kidney stones. Indian J Traditional Knowledge, 8, 191-195.
27. Kato J, Ruram AA, Singh SS, Devi SB, Devi TI, Singh WG. (2007). Lipid peroxidation and antioxidant vitamins in urolithiasis. Indian J Clin Biochem, 22, 128-130.
28. Khan SR. (2004). Crystal-induced infammation of the kidneys: Results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol, 8, 75-88.
29. Khan SR. (2005). Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res, 33, 349-357.
30. Santhosh Kumar M, Selvam R. (2003). Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem, 14, 306-313.
31. Kurien TB, Selvam R. (1989). Induction of lipid peroxidation in calcium oxalate stone formation. Indian J Exp Biol, 27, 450-453.
32. Lappas M, Permezel M, Georgiou HM, Rice GE. (2004). Regulation of phospholipase isozymes by nuclear factor-κB in human gestational tissues in vitro. J Clin Endocrinol Metab, 89, 2365-2372.
33. Li ZH, Velisek J, Zlabek V, Grabic R, Machova J, Kolarova J, Randak T. (2010). Hepatic antioxidant status and hematological parameters in rainbow trout, Oncorhynchus mykiss, after chronic exposure to carbamazepine. Chem Biol Interact, 183, 98-104.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265-275.
35. Miller C, Kennington L, Cooney R, Kohjimoto Y, Cao LC, Honeyman T, Pullman J, Jonassen J, Scheid C. (2000). Oxalate toxicity in renal epithelial cells: Characteristics of apoptosis and necrosis. Toxicol Appl Pharmacol, 162, 132-141.
36. Mishra J, Singh R. (1980). Te efect of indigenous drug Boerhaavia difusa on kidney regeneration. Indian J Pharmacol, 12, 59-64.
37. Misra HP, Fridovich I. (1972). Te generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem, 247, 6960-6962.
38. Olaleye MT, Akinmoladun AC, Ogunboye AA, Akindahunsi AA. (2010). Antioxidant activity and hepatoprotective property of leaf extracts of Boerhaavia difusa Linn against acetaminophen-induced liver damage in rats. Food Chem Toxicol, 48, 2200-2205.
39. Paglia DE, Valentine WN. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70, 158-169.
40. Pandey R, Maurya R, Singh G, Sathiamoorthy B, Naik S. (2005). Immunosuppressive properties of favonoids isolated from Boerhaavia difusa Linn. Int Immunopharmacol, 5, 541-553.
41. Puntel RL, Roos DH, Paixão MW, Braga AL, Zeni G, Nogueira CW, Rocha JB. (2007). Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: Efect of diphenyl diselenide and diphenyl ditelluride. Chem Biol Interact, 165, 87-98.
42. Rodrigo R, Bosco C. (2006). Oxidative stress and protective efects of polyphenols: Comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol, 142, 317-327.
43. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD. (1989). A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem, 53, 692-697.
44. Scheid CR, Koul HK, Kennington L, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Menon M. (1995). Oxalate-induced damage to renal tubular cells. Scanning Microsc, 9, 1097-105; discussion 1105.
45. Sellaturay S, Fry C. (2008). Te metabolic basis for urolithiasis. Surgery, 26, 136-140.
46. Selvam R. (2002). Calcium oxalate stone disease: Role of lipid peroxidation and antioxidants. Urol Res, 30, 35-47.
47. Sevil A, Ahmet A, Ergin H. (2008). Determination of antimicrobial and antioxidant activities of Turkish endemic Salvia halophila Hedge. Turk J Biol, 32, 265-270.
48. Chandan BK, Sharma AK, Anand KK. (1991). Boerhaavia difusa: A study of its hepatoprotective activity. J Ethnopharmacol, 31, 299-307.
49. Siebenlist U, Franzoso G, Brown K. (1994). Structure, regulation and function of NF-κB. Annu Rev Cell Biol, 10, 405-455.
50. Singh RH, Udupa KN. (1972). Studies on the Indian indigenous drug Punarnava (Boerhaavia difusa Linn) Part IV: Preliminary controlled clinical trial in nephrotic syndrome. J Res Indian Med, 7, 28-33.
51. Soundararajan P, Mahesh R, Ramesh T, Begum VH. (2006). Efect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol, 44, 981-986.
52. Tamilselvan S, Menon M. (2005). Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int, 96, 117-126.
53. Tamilselvan S, Selvam R. (1997). Efect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys, 34, 319-323.
54. Toblli JE, Ferder L, Stella I, De Cavanaugh EM, Angerosa M, Inserra F. (2002). Efects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol, 168, 1550-1555.